Hannover House Inc (HHSE)

[speckulater]

Post-MERGER Stock Increases Reason #11: China Theatrical Distribution












At least 11 Reasons HHSE/CRIM/Newco Stock Continues Increasing Post MERGER



#11. POST MERGER ACTIVITIES - Theatrical Distribution in China

5). POST MERGER ACTIVITIES - Besides the launch of several high-profile theatrical productions post-merger, the newly re-branded Crimson-HHSE will be (finally!) launching the VODWIZ portal, and embarking on three, very exciting new distribution ventures involving North American activities, International Sales, and Theatrical Distribution in China. It is our belief that these significant post-merger activities will have a dramatic impact on the company's revenues, visibility and valuation.

http://hannoverhousemovies.blogspot.com/2017/06/corporate-updates-on-merger-events.html




Movie Theaters in China, 2012 - 12,407
Movie Theaters in China, 2017 - 40,600

The accounting firm PwC recently estimated that China would have roughly 80,377 screens by 2021 — DOUBLE the number in the United States.

(6th Paragraph)
https://www.nytimes.com/2017/07/13/business/media/hollywood-china-box-office.html






11 REASONS HHSE/CRIM/NEWCO STOCK PRICE CONTINUES INCREASING POST MERGER

1.) Multiple Legal Issue Settlements

2.) Launch VODwiz

3.) Increased Revenues / Earnings

4.) HHSE/CRIM/Newco Uplist NASDAQ Stock Exchange

5.) Artificial Manipulation, Stock Price Boxing Completion/Exhausted

6.) 5 Significant Media Players (Chinese Based) Conduct Various Post MERGER Financial Transactions ($65,000,000 Funding)

7.) $4,000,000 HHSE/CRIM/Newco Direct Stock Purchase @ 100% Premium (Major Media Company)

8.) HHSE/CRIM/Newco Share Support. Contemporaneous with the merger, several of the China-based affiliates will be buying blocks of Crimson stock on the public markets

Additionally, Post MERGER HHSE/CRIM Embark on three, very exciting new distribution ventures that post merger activities will have a dramatic impact on the company's revenues, visibility and valuation, involving:

9.) North American Activities

10.) International Sales

11.) Theatrical Distribution In China




















HHSE